Advertisements

Лопедиум

Quick links to important sections

Лопедиум

Selected form

Advertisements
Advertisements

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Лопедиум

Quick Facts

Property Description
Active Ingredient Loperamide hydrochloride
Forms Capsules, tablets, oral solution
Pharmacological Class Antidiarrheal Agent (Opioid Receptor Agonist)
General Purpose Symptomatic control of diarrhea
Origin Synthetic compound

What Type of Medicine is Лопедиум?

Лопедиум is a specific synthetic antidiarrheal agent containing the active ingredient Loperamide hydrochloride. Pharmacologically, it is an opioid receptor agonist that acts primarily on the digestive system.

The core identity of this product is rooted in its highly selective action: Loperamide is a synthetic derivative, but its effect is almost entirely peripheral, targeting specific receptors predominantly in the intestinal wall. This mechanism of action allows for the management of bowel hyperactivity while ensuring minimal impact on the central nervous system. This peripheral action is central to its therapeutic function and differentiates it from central-acting opioid pain relievers.

Composition and General Purpose

Лопедиум is a single-ingredient product, relying solely on Loperamide hydrochloride for its therapeutic properties, and it is available in several oral dosage forms, including capsules, tablets, and a liquid oral solution. The availability of the oral solution distinguishes it, offering an alternative form for certain patient groups or those who have difficulty swallowing tablets.

The general therapeutic purpose of the medicine is to provide effective symptomatic control of diarrhea, such as that experienced during travel or minor dietary upsets. This effect is achieved by the drug's ability to decrease propulsive peristalsis (the rapid, wave-like muscle movements of the gut), which increases intestinal transit time. This action allows the intestinal lining a greater opportunity to reabsorb vital water and electrolytes. By correcting the bowel's hyperactivity and promoting rehydration, the medicine helps the body reduce the frequency and volume of loose, watery stools.

Advertisements

What side effects are possible with Лопедиум?

Possible Side Effects and Safety Information

The official safety profile for Loperamide hydrochloride, the active ingredient in Лопедиум, classifies possible adverse reactions based on their frequency as documented in government regulatory sources, along with specific safety constraints.

Frequency and System-Organ Classes

The adverse reactions are grouped into System-Organ Classes (SOCs), with the most commonly reported effects concerning Gastrointestinal Disorders and Nervous System Disorders.

Classification Common Examples (Officially Listed)
Common (ge 1/100) Constipation, flatulence, nausea, headache
Uncommon (ge 1/1,000) Dizziness, drowsiness, abdominal pain, vomiting, rash
Rare (ge 1/10,000) Loss of consciousness, stupor, ileus, urinary retention

Serious Adverse Reactions and Key Constraints

The regulatory documentation highlights the potential for serious adverse reactions, which are generally rare but clinically significant. These include severe gastrointestinal events such as Toxic Megacolon and Ileus (intestinal blockage). Of particular note are serious Cardiac Disorders, specifically QT interval prolongation, Torsades de Pointes, and other ventricular arrhythmias, especially when the medicine is used at doses exceeding recommended levels.

Population-Specific Considerations: The use of Loperamide is specifically restricted in certain groups. It is contraindicated in children under 12 years of age for over-the-counter use, and strictly restricted in children under 2 years of age. Caution is required for individuals with hepatic impairment due to the potential for increased systemic exposure and subsequent CNS toxicity.

Safety Restrictions: The medicine must not be used in conditions where the inhibition of peristalsis is to be avoided, such as certain types of infectious colitis or acute dysentery, as this can exacerbate the underlying condition. Prompt discontinuation is required if abdominal distention or constipation develops.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with loperamide (the active substance in Лопедиум) can lead to serious, potentially life-threatening health issues, particularly involving the heart and central nervous system. These risks are predominantly associated with consuming doses significantly higher than recommended for therapeutic use, including instances of intentional misuse or abuse.

Documented Overdose Symptoms

System Manifestation
Cardiovascular Serious heart problems, including abnormal heart rhythms (e.g., QT interval prolongation, Torsades de Pointes, ventricular arrhythmias), fainting (syncope), and cardiac arrest.
Central Nervous System Confusion, unresponsiveness, severe CNS depression, and respiratory depression.
Gastrointestinal Nausea and inability to urinate.

When to Seek Immediate Medical Help

Call 911 (or local emergency services) or poison control immediately if the person experiences any of the following symptoms, as they may indicate a serious overdose:

  • Fainting or unresponsiveness (the inability to wake the person or get a normal response).
  • Rapid or irregular heartbeat.
  • Trouble breathing.
  • Having a seizure or appearing collapsed.

Emergency Response Notes

In a clinical setting, naloxone may be administered to treat Central Nervous System symptoms following an overdose. Due to loperamide's long duration of action, patients require close monitoring for at least 48 hours, and repeated naloxone doses may be necessary. Use of loperamide is specifically discouraged in children younger than 2 years of age due to the heightened risk of serious breathing and heart problems.

Advertisements

Therapeutic Uses of Лопедиум

What Лопедиум Treats: Main Uses and Benefits

The active component in Лопедиум, Loperamide, is primarily used to provide supportive relief for symptoms related to physical discomfort associated with diarrhea. The medicine is commonly used for both acute episodes and for conditions where symptoms may intensify temporarily.

The medication is considered relevant for easing symptom clusters that may become intense or disruptive in conditions presenting with systemic or localized discomfort. This includes symptoms associated with acute or episodic changes, traveler's diarrhea, and conditions involving inflammatory or irritative processes like Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD).

“This support contributes to improved comfort during periods of heightened symptoms.”

Loperamide may also assist with maintaining functional stability by reducing the volume of discharge for patients with ileostomies or colostomies. It is applied across domains where additional symptomatic support is needed, helping patients cope more steadily with symptom fluctuations.


Quick Fact: Relief for symptoms that interfere with daily functioning

Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Лопедиум?

Eligibility to use Лопедиум (Loperamide) is strictly governed by regulatory guidelines, primarily focusing on age and the underlying cause of diarrhea. The drug is intended for use by adults and adolescents (typically ge 12 years, varying by region) for the symptomatic control of acute diarrhea.


Contraindicated Populations (Must Not Use)

Population/Condition Eligibility Status Reason (Official Labeling)
Children under 2 years Contraindicated Risk of respiratory/cardiac events.
Acute Dysentery Contraindicated Diarrhea with bloody stool/high fever.
Intestinal Obstruction Contraindicated Existing or developing abdominal distension, ileus, or severe constipation.
Antibiotic-associated colitis Contraindicated Specific infectious or pseudomembranous colitides.

Restricted or Conditional Use

  • Hepatic Impairment (Liver Dysfunction): Use requires caution due to reduced drug clearance and increased risk of Central Nervous System (CNS) effects.
  • Pregnancy and Lactation: Use is not recommended during breastfeeding, and during pregnancy, it should only be used if the benefit officially outweighs the potential risk to the fetus.
  • HIV/AIDS Patients with Colitis: The medication must be stopped immediately upon any signs of abdominal swelling.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents identify key interaction patterns for Loperamide (in Лопедиум) based on alterations in drug exposure and additive pharmacodynamic effects.


Interaction Scope

Category Official Regulatory Statement
Medicinal product categories with documented interactions Inhibitors of CYP3A4, CYP2C8, and P-glycoprotein (P-gp); Agents that inhibit peristalsis; Drugs that prolong the QT interval.
Specific interacting medicines (if explicitly listed) Itraconazole (up to 5-fold increase in Loperamide plasma concentration), Gemfibrozil (up to 4-fold increase), Quinidine, Ritonavir, and Oral Desmopressin.
Mechanistic basis of interactions (only if stated in label) Inhibition of Loperamide metabolism via CYP enzymes; Impairment of Loperamide efflux via P-gp; Reduction of gastrointestinal motility.
Population-specific interaction notes (if applicable) Hepatic Impairment: Interaction effects may be heightened due to increased systemic exposure of Loperamide resulting from reduced first-pass metabolism.
Interaction-related restrictions Avoid co-administration with other medicinal products known to prolong the QT interval due to the documented risk of serious cardiac adverse events (e.g., Torsades de Pointes).

Official Interaction Statements

  • Co-administration with enzyme/transporter inhibitors like Itraconazole or Gemfibrozil significantly increases Loperamide plasma concentration and systemic exposure.
  • The combination with other agents that inhibit peristalsis can lead to a pharmacodynamic additive effect, increasing the risk of paralytic ileus or toxic megacolon.
  • Alcohol use may increase the documented risk of CNS effects such as dizziness or drowsiness.

Connection to the overall interaction profile:

Regulatory documents define Loperamide's interaction structure through two pathways: the pharmacokinetic inhibition of its systemic clearance (via CYP and P-gp inhibition), which significantly increases systemic exposure; and additive pharmacodynamic effects, which heighten the risk of severe gastrointestinal sequelae or cardiac events. This profile establishes specific, high-risk combinations where official restrictions apply, notably with specific enzyme/transporter inhibitors and drugs that share adverse effects related to GI motility or cardiac conduction.

Advertisements

Mechanism of Action

The action of Loperamide hydrochloride modulates neural mechanisms of intestinal motility and fluid transport pathways. The drug is a specific mu-opioid receptor agonist and its activity is localized within the intestinal wall.


Modulating Enteric Nervous System Signaling

This core mechanism involves the drug acting as an agonist at the mu-opioid receptors found on the nerve cells of the myenteric plexus in the gastrointestinal tract. Activating these receptors initiates an inhibitory cascade, which reduces the presynaptic release of excitatory neurotransmitters like Acetylcholine and Prostaglandins. This interference reduces neural input to the smooth muscle, resulting in a decrease in propulsive peristalsis.


Influencing Intestinal Transit Time and Fluid Dynamics

The resulting physiological consequence of slowed propulsive peristalsis is a significant increase in intestinal transit time. This mechanical adjustment prolongs the duration of contact between the luminal contents and the mucosal lining, which facilitates the reabsorption of water and electrolytes. Furthermore, the mechanism inhibits the secretion of water and salts into the bowel lumen, resulting in an adjustment of fluid dynamics within the intestinal pathway.

Advertisements

Dosage and Administration Information

Instruction Map: How to use Лопедиум


Administration Scope

Route of administration: The medication is for oral administration using dosage forms such as 2 mg capsules, tablets, or liquid solutions.

Dosing schedule: For acute use in adults, the initial dose is 4 mg (two 2 mg units), followed by a subsequent 2 mg dose after each unformed stool. The maximum dose for prescribed use is 16 mg daily, while self-medication is limited to 8 mg daily. Chronic use regimens are often maintained between 4 mg and 8 mg per day.

Timing in relation to meals (if applicable): The medicine can generally be taken with or without food.

Preparation requirements (if applicable): Liquid solutions must be shaken well and administered using a calibrated measuring device to ensure accurate dosing.

Age-group administration rules: Use is not recommended for children under 2 years of age. For pediatric patients aged 2 to 12 years, the dose is determined based on weight or age, with strict daily limits. No dose adjustment is required for older adults or patients with renal impairment; however, the medicine must be used with caution in the presence of hepatic impairment.

Missed-dose rules: Since dosing for acute conditions is event-based (after a loose stool), the concept of a fixed missed dose is generally not applicable.

Special procedural conditions: For self-treatment of acute diarrhea, administration should not exceed 48 hours. Administration must cease immediately if constipation or abdominal swelling develops.


Instruction Classifications (High-Level)

Administration method type: Oral.

Frequency pattern: Event-based (as-needed) for acute use; Divided daily dosing for chronic maintenance.

Use-context constraints: Administration is constrained by the maximum dose limit and a required prompt discontinuation if adverse bowel conditions are noted.


Resulting Procedural Structure

Step sequence:

  • Take the initial 4 mg dose after the first unformed stool.
  • Take the subsequent 2 mg dose after each further unformed stool.
  • Do not exceed the daily maximum dose established for the specific use context.

Connection to the overall use protocol: The instructions establish an event-driven dosing protocol for Loperamide hydrochloride, linking administration frequency to individual bowel activity rather than fixed time schedules. This structure is defined by precise numerical starting doses and absolute daily limits, ensuring standardized application within the specified time-bound framework.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Лопедиум


Evidence for Use in Acute Diarrhea

Research exploring the effects of Loperamide has focused extensively on acute diarrhea episodes, including Traveler’s Diarrhea and other instances of short-term, non-severe intestinal upset. Researchers have used a large number of Randomized Controlled Trials (RCTs), which involve a comparison of outcomes, to measure how symptoms evolve over time in adults and children (generally those aged two and older). The research primarily focused on evaluating time-based symptom measures, such as the time required until the last unformed stool.

Studies conducted during periods of increased symptom activity reported measurements showing a pattern of difference in the duration of the diarrheal episode when comparing those who received Loperamide against those who received an inactive placebo. Specifically, the data show patterns related to a difference in the time until the last unformed stool compared to placebo. This evidence contributes to understanding symptom patterns and is generally relevant in trials assessing short-term or episodic symptom patterns, providing insight into acute changes.


Evidence for Use in Chronic Symptom Management

Loperamide was studied for its application in conditions characterized by fluctuating or episodic manifestations, particularly where symptoms become more noticeable. Research examined its use in individuals with Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) and in patients who require management of high fluid output from ileostomies or colostomies. The outcomes examined involved monitoring changes over intermediate to long-term follow-up, specifically tracking the frequency and volume of bowel movements over weeks or months.

In these observational settings evaluating daily-life functioning, some trials described patterns observed in the frequency and volume of bowel movements in chronic settings. Studies report how symptoms evolved in the observed populations, and the evidence contributes to understanding symptom patterns in conditions marked by functional limitations. Clinical guidelines acknowledge existing Observational Data that has evaluated Loperamide in patients with surgical stoma output.


What is Still Uncertain About Лопедиум Research

A number of research gaps and limitations have been identified across the studies for Loperamide. Long-term effects are not fully established, and follow-up durations were limited across most study types, particularly regarding the recurrence of symptoms.

Additionally, sample sizes were modest in some chronic condition trials, and the evidence quality varies across studies due to different measurement criteria and patient profiles. Comparative evidence evaluating study outcomes against other options is lacking in certain contexts. Research is ongoing to further characterize the long-term effects and address the variability in findings for different conditions and populations.

Key Studies & References Irritable bowel syndrome in adults: diagnosis and management (NICE Clinical Guideline CG61) (evidence for chronic IBS-D management)

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Лопедиум (FAQ)


Q: What is Lopedium used for, besides diarrhea?

Official product information states that Lopedium is used for the symptomatic control of both acute and chronic diarrhea. It is also applied to reduce the volume of discharge in patients with an ileostomy. Furthermore, regulatory documents indicate its use for managing symptoms related to certain chronic conditions, such as Diarrhea-predominant Irritable Bowel Syndrome (IBS-D).


Q: Is it true that Lopedium can be used for 'nervous' diarrhea?

Official information indicates the drug is approved for the treatment of chronic diarrhea associated with conditions like Irritable Bowel Syndrome with Diarrhea (IBS-D). While some people use the term 'nervous diarrhea' for stress-related bowel issues, information regarding its use for this specific context is best reviewed with a healthcare professional.


Q: How long after taking Lopedium does it start to work?

Based on clinical data summaries, the effects of the medication typically begin to be noticeable within 1 hour after administration. This information helps patients understand the general timeframe for symptomatic relief.


Q: Why is Lopedium sold without a prescription (over-the-counter)?

The drug was made available for over-the-counter (OTC) sale after regulatory bodies confirmed its safety and effectiveness for treating acute, non-specific diarrhea when used according to specific, strictly limited instructions. This change was based on evidence that the drug could be used safely for short-term self-treatment without continuous medical supervision.


Q: Does Lopedium differ from other medications that slow down peristalsis?

Lopedium is classified as a peripheral mu-opioid receptor agonist, meaning it acts primarily on nerve cells located directly within the intestinal wall. This localized, peripheral activity distinguishes it from central-acting opioid pain relievers, as it is not associated with central opioid effects when used as directed.


Q: Can Lopedium be taken if I have Irritable Bowel Syndrome (IBS)?

Official indications include the use of Lopedium to manage chronic diarrhea symptoms specifically associated with Diarrhea-predominant Irritable Bowel Syndrome (IBS-D). Use for this condition is generally managed under a physician's care. Official safety warnings indicate that the product should be discontinued immediately if symptoms such as constipation or abdominal swelling occur.


Q: How does Lopedium affect driving or operating machinery?

Fatigue, dizziness, or drowsiness are documented side effects of the medication, and these symptoms can also result from the underlying diarrhea itself. Official guidance contains warnings regarding operating machinery or driving until an individual's specific response to the drug is known.


Q: Have long-term studies on the safety of Lopedium been published?

Regulatory documentation confirms that Lopedium has a favorable benefit-risk profile for approved, short-term use. However, official information indicates that long-term effects and full safety when the drug is used continuously for prolonged periods are largely not fully established. Long-term administration regimens are typically established and monitored by a physician.


Q: What causes the feeling of dry mouth after taking Lopedium?

Dry mouth is a documented undesirable effect that has been noted to occur with the use of this medication. It is also important to note that this symptom can sometimes be associated with the dehydration caused by the underlying diarrhea itself.


Q: What foods or drinks affect the action of Lopedium?

Official regulatory labeling states that Lopedium can be taken with or without food. However, consuming alcohol while taking the medication may increase the documented risk of central nervous system (CNS) effects, such as dizziness or drowsiness.


Q: Can Lopedium cause addiction or dependence?

As an opioid agonist, the drug is considered to have a low risk of physical dependence when used at recommended therapeutic doses, primarily because it does not easily cross into the central nervous system. However, regulatory warnings note that taking excessively high doses can lead to opioid-like effects and increase the risk of dependence and serious heart problems.


Q: Does taking Lopedium affect blood tests or other laboratory tests?

Information from clinical toxicology reports indicates that high concentrations of Loperamide and its breakdown products might cause false positive results when testing for certain other medications, such as fentanyl, in urine immunoassay screenings.


Q: Is there a difference in effectiveness between Lopedium capsules and tablets?

All approved oral dosage forms, including capsules, tablets, and oral solutions, contain the same active ingredient. Regulatory studies, such as those for bioequivalence, generally show that all approved forms are considered equivalent in their expected clinical effects.


Q: Do I need to follow a diet when taking Lopedium?

Official instructions state the drug can be taken without regard to food. However, during treatment for acute diarrhea, general patient information often suggests avoiding certain foods and drinks to help support bowel recovery.


Q: Why is there a time limit for taking Lopedium in the instructions?

The time limit, such as not exceeding 48 hours for self-treatment, is a regulatory safety measure. This restriction is in place to help avoid serious complications like toxic megacolon or paralytic ileus, and to ensure that a healthcare professional is consulted promptly if the diarrhea is caused by a more severe underlying illness.


Q: How is Lopedium classified regarding its safety of use?

Lopedium is classified as an antidiarrheal agent and an opioid receptor agonist. While it is approved for over-the-counter (OTC) sale at specific doses, official documentation includes strict restrictions and warnings regarding age limits, use with certain types of infectious diarrhea, and the risk of serious cardiac and gastrointestinal complications if taken in overdose.


Q: Is there a 'withdrawal effect' after stopping Lopedium?

When the drug is used at approved therapeutic doses, withdrawal effects are not generally expected due to its limited action on the central nervous system. However, reports concerning chronic misuse of excessively high doses indicate that discontinuation in such instances may lead to symptoms resembling opioid withdrawal.


Q: What should be done if diarrhea does not stop after starting Lopedium?

Official instructions state that if acute diarrhea persists for more than 48 hours, or if symptoms like fever, abdominal pain, constipation, or swelling develop at any time, the medication should be discontinued immediately. The instructions emphasize the need for medical attention in these circumstances.


Q: Is there a risk that Lopedium could mask symptoms of a more serious illness?

Yes. Because Lopedium slows down bowel movements, it is contraindicated (must not be used) in cases of infectious diarrhea, such as acute dysentery, which involves fever or blood in the stool. Slowing the gut can worsen the underlying condition or delay the clearance of toxins, potentially masking the progression of a serious illness.


Q: What is known about Lopedium overdose from official data?

Regulatory safety warnings indicate that overdose, including relative overdose due to liver impairment, can cause central nervous system depression (drowsiness, stupor) and urinary retention. Critically, it can also lead to serious cardiac abnormalities, such as QT interval prolongation and ventricular arrhythmias.


Q: Can Lopedium interact with herbal supplements?

The official prescribing information does not specifically detail interactions with herbal supplements. However, because some herbal products may affect drug metabolism pathways (like CYP enzymes), regulatory bodies provide general information highlighting the importance of informing a healthcare provider about all medicines and supplements being taken.


Q: What components of Lopedium, besides the active ingredient, can cause allergies?

Lopedium is strictly contraindicated if there is a known hypersensitivity to Loperamide hydrochloride or to any of the inactive ingredients, known as excipients. Official documents list these excipients, which may include substances like benzyl alcohol or traces of sulfites, that are known to potentially cause allergic reactions in sensitive individuals.


Q: Why should Lopedium be avoided in cases of ulcerative colitis?

Lopedium is contraindicated in cases of acute, severe flares of ulcerative colitis and other conditions where inhibiting peristalsis could be harmful. Slowing the bowel's movement in these situations can lead to serious and life-threatening complications, most notably toxic megacolon.


Q: How do studies assess the benefit-risk ratio of Lopedium?

Based on decades of clinical experience and evidence, regulatory agencies generally affirm that Lopedium has a favorable benefit-risk profile for its approved uses. This means that, when taken according to official instructions and subject to all stated warnings, the benefits in controlling diarrhea symptoms outweigh the potential risks.


Q: How can one tell if diarrhea is caused by an infection, and can Lopedium be taken then?

Lopedium is specifically contraindicated if the diarrhea is accompanied by a high fever or blood in the stool, as these symptoms often point to acute dysentery or other infectious colitides. In these cases, it is contraindicated (must not be used), as slowing peristalsis can be dangerous, and the product information emphasizes the need to consult a healthcare professional.


Q: Is it true that Lopedium can be used to 'prevent' traveler’s diarrhea?

Official guidance indicates that Lopedium is approved for the treatment of acute diarrhea, including Traveler’s Diarrhea. However, its use for prophylaxis (prevention) is not an officially approved indication, and official information does not recommend its use for prophylaxis without a specific medical determination.

Advertisements

How should Лопедиум be stored and disposed of?

How to Store and Dispose of Лопедиум?

The storage and disposal of Лопедиум (Loperamide) must align strictly with government-approved regulatory requirements to ensure product integrity and public safety.

Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature, typically 20^circC to 25^circC (68^circF to 77^circF), and always below 30^circC.
Protection Protect from light and excessive heat (above 40^circC). Do not use if the original seal or blister packaging is broken or torn.
Safety The medicine must be kept out of the sight and reach of children.

Disposal Instructions

Unused or expired Лопедиум should not be disposed of in wastewater or regular household trash (unless prepared specifically). Regulators recommend utilizing a drug take-back program. If no program is available, the product must be mixed with an unappealing substance, placed in a sealed bag, and then discarded with household waste, following official pharmaceutical waste handling guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Лопедиум found in:

A-Z Index: